ECSP088621A - Derivados de triazoloanilinopirimidina para uso como agentes antivirales - Google Patents
Derivados de triazoloanilinopirimidina para uso como agentes antiviralesInfo
- Publication number
- ECSP088621A ECSP088621A EC2008008621A ECSP088621A ECSP088621A EC SP088621 A ECSP088621 A EC SP088621A EC 2008008621 A EC2008008621 A EC 2008008621A EC SP088621 A ECSP088621 A EC SP088621A EC SP088621 A ECSP088621 A EC SP088621A
- Authority
- EC
- Ecuador
- Prior art keywords
- triazoloanylinopirimidine
- derivatives
- antiviral agents
- formula
- prevention
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Abstract
Un derivado de quinazolina de fórmula (I), o una sal farmacéuticamente aceptable del mismo: formula (I) para uso en el tratamiento de prevención de una infección por flaviviridae.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0600510A GB0600510D0 (en) | 2006-01-11 | 2006-01-11 | Chemical compounds |
GB0612116A GB0612116D0 (en) | 2006-06-19 | 2006-06-19 | Chemical Compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP088621A true ECSP088621A (es) | 2008-08-29 |
Family
ID=37888130
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EC2008008621A ECSP088621A (es) | 2006-01-11 | 2008-07-11 | Derivados de triazoloanilinopirimidina para uso como agentes antivirales |
Country Status (15)
Country | Link |
---|---|
US (1) | US20100158863A1 (es) |
EP (1) | EP1981876B1 (es) |
JP (1) | JP2009523163A (es) |
KR (1) | KR20080083139A (es) |
AT (1) | ATE508125T1 (es) |
AU (1) | AU2007204227B2 (es) |
BR (1) | BRPI0706412A2 (es) |
CA (1) | CA2635916A1 (es) |
DE (1) | DE602007014324D1 (es) |
EC (1) | ECSP088621A (es) |
IL (1) | IL191928A0 (es) |
NZ (1) | NZ569703A (es) |
RU (1) | RU2008132806A (es) |
TW (1) | TW200902515A (es) |
WO (1) | WO2007080401A1 (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7759495B2 (en) | 2006-08-11 | 2010-07-20 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
US7745636B2 (en) | 2006-08-11 | 2010-06-29 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
US7659270B2 (en) | 2006-08-11 | 2010-02-09 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
US8303944B2 (en) | 2006-08-11 | 2012-11-06 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
US8329159B2 (en) | 2006-08-11 | 2012-12-11 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
JP2011511841A (ja) * | 2008-02-12 | 2011-04-14 | ブリストル−マイヤーズ スクイブ カンパニー | C型肝炎ウイルス阻害剤 |
CN102552271B (zh) | 2010-12-09 | 2014-08-06 | 中国科学院上海药物研究所 | 一类喹唑啉类化合物在制备抗黄病毒科病毒的药物中的用途 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0912559B1 (en) * | 1996-07-13 | 2002-11-06 | Glaxo Group Limited | Fused heterocyclic compounds as protein tyrosine kinase inhibitors |
WO2000004900A1 (en) * | 1998-07-20 | 2000-02-03 | Bristol-Myers Squibb Company | Substituted benzimidazole antiviral agents |
US20030176454A1 (en) * | 2000-05-15 | 2003-09-18 | Akira Yamada | N-coating heterocyclic compounds |
CL2004000234A1 (es) * | 2003-02-12 | 2005-04-15 | Biogen Idec Inc | Compuestos derivados 3-(piridin-2-il)-4-heteroaril-pirazol sustituidos, antagonistas de aik5 y/o aik4; composicion farmaceutica y uso del compuesto en el tratamiento de desordenes fibroticos como esclerodermia, lupus nefritico, cicatrizacion de herid |
EP1748991A1 (en) * | 2004-04-28 | 2007-02-07 | Arrow Therapeutics Limited | Morpholinylanilinoquinazo- line derivatives for use as antiviral agents |
GB0501964D0 (en) * | 2005-01-31 | 2005-03-09 | Arrow Therapeutics Ltd | Chemical compounds |
US8143288B2 (en) * | 2005-06-06 | 2012-03-27 | Bristol-Myers Squibb Company | Inhibitors of HCV replication |
GB0520475D0 (en) * | 2005-10-07 | 2005-11-16 | Arrow Therapeutics Ltd | Chemical compounds |
-
2007
- 2007-01-11 KR KR1020087016748A patent/KR20080083139A/ko not_active Application Discontinuation
- 2007-01-11 CA CA002635916A patent/CA2635916A1/en not_active Abandoned
- 2007-01-11 JP JP2008549924A patent/JP2009523163A/ja active Pending
- 2007-01-11 DE DE602007014324T patent/DE602007014324D1/de active Active
- 2007-01-11 WO PCT/GB2007/000065 patent/WO2007080401A1/en active Application Filing
- 2007-01-11 RU RU2008132806/04A patent/RU2008132806A/ru not_active Application Discontinuation
- 2007-01-11 AU AU2007204227A patent/AU2007204227B2/en not_active Ceased
- 2007-01-11 NZ NZ569703A patent/NZ569703A/en unknown
- 2007-01-11 AT AT07704895T patent/ATE508125T1/de not_active IP Right Cessation
- 2007-01-11 US US12/160,506 patent/US20100158863A1/en not_active Abandoned
- 2007-01-11 EP EP07704895A patent/EP1981876B1/en active Active
- 2007-01-11 BR BRPI0706412-8A patent/BRPI0706412A2/pt not_active IP Right Cessation
- 2007-07-11 TW TW096125306A patent/TW200902515A/zh unknown
-
2008
- 2008-06-03 IL IL191928A patent/IL191928A0/en unknown
- 2008-07-11 EC EC2008008621A patent/ECSP088621A/es unknown
Also Published As
Publication number | Publication date |
---|---|
DE602007014324D1 (de) | 2011-06-16 |
EP1981876A1 (en) | 2008-10-22 |
CA2635916A1 (en) | 2007-07-19 |
EP1981876B1 (en) | 2011-05-04 |
WO2007080401A1 (en) | 2007-07-19 |
KR20080083139A (ko) | 2008-09-16 |
JP2009523163A (ja) | 2009-06-18 |
BRPI0706412A2 (pt) | 2011-03-29 |
RU2008132806A (ru) | 2010-02-20 |
AU2007204227A1 (en) | 2007-07-19 |
AU2007204227B2 (en) | 2011-03-03 |
TW200902515A (en) | 2009-01-16 |
IL191928A0 (en) | 2008-12-29 |
ATE508125T1 (de) | 2011-05-15 |
US20100158863A1 (en) | 2010-06-24 |
WO2007080401A8 (en) | 2008-07-24 |
NZ569703A (en) | 2011-07-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP088367A (es) | Derivados de bifenilo y su uso en el tratamiento de la hepatitis c | |
EA200870193A1 (ru) | Цитотоксические агенты, включающие новые производные томаймицина, и их терапевтическое применение | |
ATE460158T1 (de) | Purin-derivate als a2a-rezeptor-agonisten | |
NI201300107A (es) | Derivados de nucleósidos 2' - sustituidos y métodos de uso de los mismos para el tratamiento de enfermedades virales. | |
SV2009003299A (es) | Derivados de dihidropiridina de utilidad como inhibidores de la proteina quinasa | |
ECSP099436A (es) | Acilaminopirazoles como inhibidores de fgfr | |
ATE524465T1 (de) | 2-carboxy-thiophen-derivate als viruzide | |
TW200738725A (en) | Unsaturated mTOR inhibitors | |
TNSN08326A1 (en) | Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments | |
EA201200049A1 (ru) | 1,3-дизамещенные производные имидазолидин-2-она в качестве ингибиторов cyp 17 | |
ECSP088621A (es) | Derivados de triazoloanilinopirimidina para uso como agentes antivirales | |
CR11684A (es) | Dihidropirazolonas sustituidas de hif-propil-4- como inhibidores hidroxilasa | |
GT200600081A (es) | Derivados de acetilenno | |
TW200740776A (en) | N-phenylbenzotriazolyl c-kit inhibitors | |
MX2012006026A (es) | Derivados de acido 5-alquinil-tiofen-2-carboxilico y usos para tratamiento o prevencion de infecciones por flavivirus. | |
CR11825A (es) | Derivados de urea heterociclicos para el tratamiento de infecciones bacterianas | |
ECSP099506A (es) | Derivados de 2-quinolinona y 2 quinoxalinona y su utilización como agentes anti bacterianos | |
UY29859A1 (es) | Derivados de 1-amino-isiquinolina,su preparación y su aplicación terapéutica | |
ATE496918T1 (de) | Als a2b-adenosinrezeptorantagonisten geeignete 5- phenyl-6-pyridin-4-yl-1,3-dihydro-2h-imidazoä4, - büpyridin-2-onderivate | |
TNSN08369A1 (en) | Benzimidazole derivatives | |
UY29358A1 (es) | Tiazolidinonas, su preparacion y su uso como medicamento | |
CR9058A (es) | Derivados de indol como inhibidores de la adenilato ciclasa soluble | |
CO6382113A2 (es) | Compuestos quimicos | |
IL195837A0 (en) | 4-amino-3-arylamino-6-arylpyrazolo[3,4-d] | |
MX2009005912A (es) | Derivados de etilamina-fenilo heterociclilo sustituidos, su preparacion y uso como medicamentos. |